| NDC Code | 51662-1420-1 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1420-1) / 10 mL in 1 VIAL, MULTI-DOSE |
|---|
| Product NDC | 51662-1420 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Nalbuphine Hci |
|---|
| Non-Proprietary Name | Nalbuphine Hci |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20191029 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA070915 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|
| Substance Name | NALBUPHINE HYDROCHLORIDE |
|---|
| Strength | 10 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA] |
|---|